Vicapsys Life Sciences, Inc. (VICP)
OTCMKTS · Delayed Price · Currency is USD
1.000
0.00 (0.00%)
At close: Sep 1, 2026
Vicapsys Life Sciences Market Cap
Vicapsys Life Sciences has a market cap or net worth of $32.37 million as of September 8, 2026. Its market cap has decreased by -43.50% in one year.
Market Cap
32.37M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.00
ChartMarket Cap Chart
Since January 5, 2018, Vicapsys Life Sciences's market cap has increased from 9.76M to 32.37M, an increase of 231.67%. That is a compound annual growth rate of 14.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 32.37M | 101,160,209.38% |
| Dec 10, 2024 | 32.00 | -100.00% |
| Dec 20, 2023 | 87.88M | 1,045.91% |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 66.70M |
| Nuo Therapeutics | 58.60M |
| Arch Biopartners | 50.27M |
| BetterLife Pharma | 35.87M |
| Cell Source | 35.13M |
| ProText Mobility | 30.77M |
| Provectus Biopharmaceuticals | 25.22M |
| Biomind Labs | 19.42M |